Pd22-10 Virtual Reality With Biofeedback Enhances Tolerability of Office Based Transperineal Prostate Biopsy

You have accessJournal of UrologySurgical Technology & Simulation: Instrumentation & Technology I (PD22)1 May 2024PD22-10 VIRTUAL REALITY WITH BIOFEEDBACK ENHANCES TOLERABILITY OF OFFICE BASED TRANSPERINEAL PROSTATE BIOPSY John M. Myrga, Divya Natesan, Christopher J. Staniorski, Michael Stencel, Bruce L. Jacobs, and Benjamin J. Davies John M. MyrgaJohn M. Myrga , Divya NatesanDivya Natesan , Christopher J. StaniorskiChristopher J. Staniorski , Michael StencelMichael Stencel , Bruce L. JacobsBruce L. Jacobs , and Benjamin J. DaviesBenjamin J. Davies View All Author Informationhttps://doi.org/10.1097/01.JU.0001009504.18450.e0.10AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Transperineal biopsy is becoming increasingly utilized to detect prostate cancer. One significant drawback is patients find transperineal biopsy more painful, anxiety-provoking, and embarrassing, limiting their use in an office-based setting. We examined three non-anesthetic pain management interventions; aromatherapy, a virtual reality device alone, and a virtual reality device that incorporates biofeedback techniques. We hypothesize that patients will find them useful in managing pain and anxiety during their procedure. METHODS: We utilized tumescent perineal anesthesia for our biopsies without any anxiolytics. For our virtual reality arm, we selected the Meta Quest® 2 virtual reality headset where patients watched an underwater oceanscape video with meditative audio. Our virtual reality with biofeedback arm utilized the Flowly® immersive virtual world with guided breathing exercises incorporating a heart rate sensor. Our aromatherapy arm utilized the Elquil® Aromatab with lavender/peppermint scent. Following the procedure, patients completed a visual analog scale (VAS) of 0-10 to rate their pain during the biopsy. Patients also answered questions regarding pain, embarrassment, anxiety, and perceived utility of the intervention. RESULTS: We recruited 62 patients. As seen in Table 1, compared to aromatherapy and virtual reality arms, the biofeedback group had lower periprocedural pain scores. They also had lower rates of embarrassment and anxiety during the procedure. Rates of distraction were significantly different between the groups, favoring biofeedback (p<0.01). CONCLUSIONS: Patients are interested in using adjuncts for pain management during prostate biopsy. Patients especially found the Flowly device, which incorporated virtual reality and biofeedback, to be distracting and showed the lowest rates of periprocedural discomfort. Utilizing virtual reality with biofeedback may provide further improvements in office-based tolerability of transperineal biopsy and larger studies comparing these approaches are warranted. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e465 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information John M. Myrga More articles by this author Divya Natesan More articles by this author Christopher J. Staniorski More articles by this author Michael Stencel More articles by this author Bruce L. Jacobs More articles by this author Benjamin J. Davies More articles by this author Expand All Advertisement PDF downloadLoading ...